Financial Performance: Revenue, earnings, and profit margins directly impact investor confidence and stock valuation.

Market Sentiment: Overall investor mood and prevailing market trends influence buying and selling decisions.

Industry Trends: Developments and growth prospects within the healthcare sector, particularly related to diabetes, affect stock performance.

Company News: Announcements regarding drug development, clinical trials, regulatory approvals, and partnerships can cause price fluctuations.

Economic Conditions: Macroeconomic factors like interest rates, inflation, and GDP growth can impact overall market valuations.

Regulatory Changes: Government policies and regulations in the pharmaceutical industry significantly influence profitability and market access.

Competition: The presence and activities of rival companies in the diabetes care market affect market share and pricing strategies.

Risk Factors: Potential risks associated with drug development, clinical trials, and market competition impact investor perception and stock price.

Investor Perception: How investors view the company's future prospects and growth potential drives demand and stock price.

Dividend Policy: Dividend payments and payout ratios can attract income-seeking investors and influence stock valuation.